Abbott’s Earnings Guidance Unchanged With Questions On Formula Recall Unanswered

Latest announcement about recall not reported in SEC filing came in FDA posting of Abbott’s announcement concerning an expansion of firm’s recall to include an additional lot of Similac powder.